[Role of Helicobacter pylori eradication in the prevention of peptic ulcer in NSAID users].
Helicobacter pylori (H. pylori) and non-steroidal anti-inflammatory drug (NSAID) are independent risk factors for peptic ulcers and ulcer complications and they have additive or synergistic effects. A meta-analysis showed that the OR for the incidence of peptic ulcer was 61.1 in patients infected with H. pylori and also taking NSAID when compared to patients uninfected with H. pylori and not taking NSAID. H. pylori eradication may prevent NSAID-induced ulcers in NSAID naive patients. In patients receiving long-term NSAID, proton pump inhibitor(PPI) is more effective in the prevention of ulcer recurrence and bleeding. However, H. pylori eradication should be considered in patients receiving long -term PPI maintenance treatment to prevent the development of corpus gastritis and gastric atrophy.
Shimada
Tadahito
T
Department of Gastroenterology, Dokkyo Medical University.
Yamagata
Michiko
M
Hiraishi
Hideyuki
H
D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000009:adverse effects* / Q000819:agonists*; D016481:Helicobacter Infections / Q000188:drug therapy*; D016480:Helicobacter pylori; D006801:Humans; D010437:Peptic Ulcer / Q000139:chemically induced* / Q000382:microbiology / Q000517:prevention & control*
D000894:Anti-Inflammatory Agents, Non-Steroidal